Ketamine (Perioperative — Opioid-Sparing Analgesia)
Brand names: Ketalar
Ketamine is used perioperatively at low (sub-anaesthetic) infusion or bolus levels as an opioid-sparing analgesic adjunct, particularly in major surgery, opioid-tolerant patients and where chronic post-surgical pain is a concern.
The product information we hold does not support a dose for this page's specific use, route or population, so none is shown. Follow your local or national guideline, and confirm against the product SmPC.
The licensed dosing — for the medicine's licensed uses, which may differ from this page's — is on Ketamine.
Clinical monograph
How it works
It is principally an NMDA-receptor antagonist; blockade of these receptors reduces central sensitisation and opioid-induced hyperalgesia, providing analgesia distinct from opioid pathways.
Prescribing in practice
- Use under protocols in a monitored environment, as ketamine can cause psychotomimetic effects, raise blood pressure and heart rate, and should be used cautiously in uncontrolled hypertension, raised intracranial pressure or significant cardiac disease.
- Reserve low-dose analgesic regimens for appropriate cases (major or opioid-tolerant surgery) and prescribe as part of a multimodal plan rather than as sole analgesia.
- Avoid or use cautiously where there is a history of psychosis; emergence reactions can be mitigated by concurrent benzodiazepine and a calm recovery environment.
Monitoring
Monitor conscious level, blood pressure, heart rate and for dissociative or psychotomimetic effects during infusion, with pain scores to titrate the opioid-sparing benefit.
Counselling the patient
- Explain a low-dose infusion may be used to improve pain control and reduce the amount of strong opioid needed.
- Mention that vivid dreams or a floating sensation can occur and to tell staff if these are distressing.
Evidence & guidelines
Low-dose perioperative ketamine for opioid-sparing analgesia is supported by consensus guidelines and trial evidence in major and opioid-tolerant surgery, used off the anaesthetic licence under specialist protocols.
Reference: RCoA Acute Pain Handbook; AAGBI Ketamine Guidelines; Cochrane Ketamine-PONV Review; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- ASA Physical Status Classification · Pre-operative Risk
- Morphine Milligram Equivalents (MME) Calculator · Pain / Opioids
- Opioid Conversion / Equianalgesic Guide · Pain Management
- Numeric Rating Scale (NRS) for Pain · Pain Assessment
- Local Anaesthetic Maximum Dose Calculator · Drug Dosing
- POSSUM Score for Surgical Morbidity and Mortality · Perioperative Risk
- Major Trauma — Primary Survey (ATLS) · ATLS 10th Edition; JRCALC; NICE NG39
- Major Haemorrhage / Massive Transfusion · BCSH; RCOA; RCEM; RCS — BCSH Guidelines
- Burns — TBSA Estimation & Fluid Resuscitation · British Burn Association; EMSB; RCEM 2024
- Lower Gastrointestinal Bleed · NICE; BSG; ACPGBI — Commissioning Guide
- Acute Pancreatitis · NICE; IAP/APA; ACPGBI — CG104
- Hypertrophic Pyloric Stenosis · BAPS / RCPCH